Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04745910 | Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome | completed | Phase 4 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT04319198 | Rollover Study in Participants With Metastatic Solid Tumors Benefiting From Therapy With Sacituzumab Govitecan-hziy | completed | Phase 4 | 25 | Gilead SciencesINDUSTRY | 3 | Sep 30, 2025 | clinicaltrials |
| NCT04078152 |
| Durvalumab Long-Term Safety and Efficacy Study(WAVE) |
| completed |
| Phase 4 |
| 163 |
| AstraZenecaINDUSTRY |
| 31 |
| Dec 20, 2024 |
| clinicaltrials |
| NCT05054998 | Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases | completed | Phase 4 | 12 | M.D. Anderson Cancer CenterOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT02688881 | Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid Tumors | completed | Phase 4 | 6 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02691793 | Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors | completed | Phase 4 | 1 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02095951 | Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection | completed | Phase 4 | 30 | Children's Hospital of MichiganOTHER | 1 | Dec 19, 2018 | clinicaltrials |
| NCT02805166 | PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy | completed | Phase 4 | 420 | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.INDUSTRY | 0 | Jun 17, 2016 | clinicaltrials |
| NCT00378937 | Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain | completed | Phase 4 | 30 | University Hospitals Bristol and Weston NHS Foundation TrustOTHER | 0 | Aug 2, 2013 | clinicaltrials |
| NCT00003252 | Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy | completed | Phase 4 | — | Rush North Shore Medical CenterOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00808184 | Pharmacokinetic Study of CPT-11, Raltegravir and Midazolam With Characterisation of UGT1A1 Genotype | completed | Phase 4 | 25 | National University Hospital, SingaporeOTHER | 1 | Nov 1, 2012 | clinicaltrials |
Data updated 22 days agoSource updated May 6, 2026source: clinicaltrials